Abstract
Among Asian-American men and women, lung cancer is the second most commonly occurring cancer and primary cause of cancer-related mortality. Collectively, Asian-American men and women have a lower incidence rate of lung cancer than their non-Hispanic white counterparts. However, there is considerable heterogeneity in incidence rates across Asian-American subgroups, some of whom experience increasing rates of lung cancer and/or rates similar to non-Hispanic Whites. Active cigarette smoking is the primary risk factor for lung cancer; cigarette smoking may be influenced by education, acculturation, and access to health care. Among never smokers, Asian-American women experience a higher risk of lung cancer in comparison to Asian-American men and non-Hispanic white women; and additional risk factors such as indoor- and outdoor air pollution, passive smoking, and lifestyle factors should be considered. In order to aid in disease prevention and improve survival through early stage diagnosis, further work towards understanding risk factors in never smokers as well as identifying at-risk individuals in this growing US population are needed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29
Reeves TJ, Bennett CE. United States Census Bureau. American Community Survey. Census 2000 Special Reports. https://www.census.gov/prod/2004pubs/censr-17.pdf
Department of Health and Human Services (1998) Tobacco use among US racial/ethnic minority groups—African–Americans, American–Indians and Alaska Natives, Asian-Americans and Pacific Islanders, and Hispanics: a report of the Surgeon General. Centers for Disease Control and Prevention, Atlanta
Fast Stats: an interactive tool for access to SEER cancer statistics. http://seer.cancer.gov/faststats
Gomez SL, Noone A-M, Lichtensztajn DY et al (2013) Cancer incidence trends among Asian American populations in the United States, 1990–2008. J Natl Cancer Inst 105(15):1096–1110
Yin D, Morris C, Allen M et al (2010) Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups? Cancer Causes Control 21(10):1721–1730
Gomez SL, Chang ET, Shema SJ et al (2011) Survival following non–small cell lung cancer among Asian/Pacific Islander, Latina, and non-Hispanic White women who have never smoked. Cancer Epidemiol Biomarkers Prev 20(3):545–554
Thun MJ, Hannan LM, Adams-Campbell LL et al (2008) Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 5(9):e185
Raz DJ, Gomez SL, Chang ET et al (2008) Epidemiology of non-small cell lung cancer in Asian Americans: incidence patterns among six subgroups by nativity. J Thorac Oncol 3(12):1391–1397
Howlader N, Noone A, Krapcho M, et al (2015) SEER Cancer Statistics Review, 1975–2012. http://seer.cancer.gov/csr/1975_2012, based on November 2014 SEER data submission, posted to the SEER web site, April 2015
Cheng I, Le GM, Noone A-M et al (2014) Lung cancer incidence trends by histology type among Asian American, native Hawaiian, and Pacific Islander populations in the United States, 1990–2010. Cancer Epidemiol Biomarkers Prev 23(11):2250–2265
Trinh Q-D, Nguyen PL, Leow JJ et al (2015) Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment. J Natl Cancer Inst 107(6):djv054
Chang ET, Shema SJ, Wakelee HA et al (2009) Uncovering disparities in survival after non–small–cell lung cancer among Asian/Pacific Islander ethnic populations in California. Cancer Epidemiol Biomarkers Prev 18(8):2248–2255
Soo RA, Loh M, Mok TS et al (2011) Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trials. J Thorac Oncol 6(6):1030–1038
Janssen-Heijnen MLG, Coebergh J-WW (2001) Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 31(2–3):123–137
Travis WD, Travis LB, Devesa SS (1995) Lung cancer. Cancer 75(1 Suppl):191–202
Wynder EL, Muscat JE (1995) The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect 103(Suppl 8):143–148
Lewis DR, Check DP, Caporaso NE et al (2014) US lung cancer trends by histologic type. Cancer 120(18):2883–2892
Meza R, Meernik C, Jeon J et al (2015) Lung cancer incidence trends by gender, race and histology in the United States, 1973–2010. PLoS One 10(3):e0121323
Burns DM, Anderson CM, Gray N (2011) Do changes in cigarette design influence the rise in adenocarcinoma of the lung? Cancer Causes Control 22(1):13–22
CDC (2001) Women and smoking: a report of the Surgeon General. Centers for Disease Control and Prevention, Atlanta
Riely GJ, Kris MG, Rosenbaum D et al (2008) Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin Cancer Res 14(18):5731–5734
Corvalan A, Witstuba II (2010) Molecular pathology of lung cancer. In: Stewart DJ (ed) Lung cancer. Springer, Berlin, pp 1–25
Suzuki M, Shigematsu H, Iizasa T et al (2006) Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer. Cancer 106(10):2200–2207
Lung ML, Wong M, Lam WK et al (1992) Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer 70(4):760–763
Wang YC, Lee HS, Chen SK et al (1998) Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome. J Cancer Res Clin Oncol 124(9):517–522
Soussi T. The TP53 website. http://p53.free.fr/index.html
Toyooka S, Tsuda T, Gazdar AF (2003) The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 21(3):229–239
Hainaut P, Pfeifer GP (2001) Patterns of p53 G → T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 22(3):367–374
Wang Y-C, Chen C-Y, Chen S-K et al (1998) High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Cancer Res 58(2):328–333
Lung ML, Wong MP, Skaanild MT et al (1996) P53 mutations in non-small cell lung carcinomas in Hong Kong. Chest 109(3):718–726
Gao HG, Chen JK, Stewart J et al (1997) Distribution of p53 and K-ras mutations in human lung cancer tissues. Carcinogenesis 18(3):473–478
Krishnan VG, Ebert PJ, Ting JC et al (2014) Whole-genome sequencing of Asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers. Cancer Res 74(21):6071–6081
Takagi Y, Osada H, Kuroishi T et al (1998) p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking. Br J Cancer 77(10):1568–1572
Mitsudomi T (2014) Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations. Transl Lung Cancer Res 3(4):205–211
Shigematsu S (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97:339–346
Paez JG (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497–1500
Lynch TJ (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129–2139
Kosaka T (2004) Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 64:8919–8923
Shigematsu H, Takahashi T, Nomura M et al (2005) Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res 65(5):1642–1646
Sohn HS, Kwon JW, Shin S et al (2015) Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis. J Clin Pharm Ther 40(6):661–671. doi:10.1111/jcpt.12332:n/a-n/a
Ji H, Ramsey MR, Hayes DN et al (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448(7155):807–810
Koivunen JP, Kim J, Lee J et al (2008) Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer 99(2):245–252
Inamura K, Takeuchi K, Togashi Y et al (2008) EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. J Thorac Oncol 3(1):13–17
Wong DW-S, Leung EL-H, So KK-T et al (2009) The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 115(8):1723–1733
Soda M, Choi YL, Enomoto M et al (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448(7153):561–566
Koivunen JP, Mermel C, Zejnullahu K et al (2008) EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 14(13):4275–4283
IARC (2004) Monographs on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking. IARC, Lyon
Centers for Disease Control (1989) The Surgeon General’s 1989 report on reducing the health consequences of smoking: 25 years of progress. U.S. Department of Health and Human Services, Atlanta
Shopland DR (1995) Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect 103(Suppl 8):131–142
Pesch B, Kendzia B, Gustavsson P et al (2012) Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies. Int J Cancer 131(5):1210–1219
Seki T, Nishino Y, Tanji F et al (2013) Cigarette smoking and lung cancer risk according to histologic type in Japanese men and women. Cancer Sci 104(11):1515–1522
Haiman CA, Stram DO, Wilkens LR et al (2006) Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 354(4):333–342
Le Marchand L, Wilkens LR, Kolonel LN (1992) Ethnic differences in the lung cancer risk associated with smoking. Cancer Epidemiol Biomarkers Prev 1(2):103–107
Derby KS, Cuthrell K, Caberto C et al (2008) Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer. Cancer Epidemiol Biomarkers Prev 17(12):3526–3535
Centers for Disease Control and Prevention (2015) Current cigarette smoking among adults—United States, 2005–2014. Morb Mortal Wkly Rep 64(44):1233–1240
Asian American Smoking Prevalence Ranges. http://www.appealforcommunities.org/wp-content/uploads/2014/06/1653_AsianAmericanprevalenceranges2013.pdf
Chae DH, Gavin AR, Takeuchi DT (2006) Smoking prevalence among Asian Americans: findings from the National Latino and Asian American Study (NLAAS). Public Health Rep 121(6):755–763
Choi S, Rankin S, Stewart A et al (2008) Effects of acculturation on smoking behavior in Asian Americans: a meta-analysis. J Cardiovasc Nurs 23(1):67–73
Fu SS, Ma GX, Tu XM et al (2003) Cigarette smoking among Chinese Americans and the influence of linguistic acculturation. Nicotine Tob Res 5(6):803–811
Tang H, Shimizu R, Chen MS (2005) English language proficiency and smoking prevalence among California’s Asian Americans. Cancer 104(S12):2982–2988
Chen X, Unger JB (1999) Hazards of smoking initiation among Asian American and non-Asian adolescents in California: a survival model analysis. Prev Med 28(6):589–599
Muggli ME, Pollay RW, Lew R et al (2002) Targeting of Asian Americans and Pacific Islanders by the tobacco industry: results from the Minnesota Tobacco Document Depository. Tob Control 11(3):201–209
Jha P, Ramasundarahettige C, Landsman V et al (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368(4):341–350
Pirie K, Peto R, Reeves GK et al (2013) The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 381(9861):133–141
Sakata R, McGale P, Grant EJ et al (2012) Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study. BMJ 345:e7093
Kim CH, Lee Y-CA, Hung RJ et al (2014) Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). Int J Cancer 135(8):1918–1930
Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers—a different disease. Nat Rev Cancer 7(10):778–790
Lee CH, Ko YC, Goggins W et al (2000) Lifetime environmental exposure to tobacco smoke and primary lung cancer of non-smoking Taiwanese women. Int J Epidemiol 29(2):224–231
Clement-Duchene C, Vignaud JM, Stoufflet A et al (2010) Characteristics of never smoker lung cancer including environmental and occupational risk factors. Lung Cancer 67(2):144–150
Brenner DR, Hung RJ, Tsao MS et al (2010) Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors. BMC Cancer 10:285
Kurahashi N, Inoue M, Liu Y et al (2008) Passive smoking and lung cancer in Japanese non-smoking women: a prospective study. Int J Cancer 122(3):653–657
Veglia F, Vineis P, Overvad K et al (2007) Occupational exposures, environmental tobacco smoke, and lung cancer. Epidemiology 18(6):769–775
Taylor R, Najafi F, Dobson A (2007) Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol 36(5):1048–1059
Darby S (2005) Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case–control studies. BMJ 330:223
Torres-Durán M, Barros-Dios JM, Fernández-Villar A et al (2014) Residential radon and lung cancer in never smokers. A systematic review. Cancer Lett 345(1):21–26
Darby S, Hill D, Deo H et al (2006) Residential radon and lung cancer—detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health 32(Suppl 1):1–83
Lubin JH, Wang ZY, Boice JD et al (2004) Risk of lung cancer and residential radon in China: pooled results of two studies. Int J Cancer 109(1):132–137
Lee T, Gany F (2013) Cooking oil fumes and lung cancer: a review of the literature in the context of the U.S. population. J Immigr Minor Health 15(3):646–652
Lam WK (2005) Lung cancer in Asian women—the environment and genes*. Respirology 10(4):408–417
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2010) Household use of solid fuels and high-temperature frying. IARC Monogr Eval Carcinog Risks Hum 95:1–430
Hosgood HD 3rd, Boffetta P, Greenland S et al (2010) In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium. Environ Health Perspect 118(12):1743–1747
Kurmi OP, Arya PH, Lam KB et al (2012) Lung cancer risk and solid fuel smoke exposure: a systematic review and meta-analysis. Eur Respir J 40(5):1228–1237
Hosgood HD, Wei H, Sapkota A et al (2011) Household coal use and lung cancer: systematic review and meta-analysis of case–control studies, with an emphasis on geographic variation. Int J Epidemiol 40(3):719–728
Shields PG, Xu GX, Blot WJ et al (1995) Mutagens from heated Chinese and U.S. cooking oils. J Natl Cancer Inst 87(11):836–841
Gao Y-T, Blot WJ, Zheng W et al (1987) Lung cancer among Chinese women. Int J Cancer 40(5):604–609
Metayer C, Wang Z, Kleinerman RA et al (2002) Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer 35(2):111–117
Wang TJ, Zhou BS, Shi JP (1996) Lung cancer in nonsmoking Chinese women: a case–control study. Lung Cancer 14(Suppl 1):S93–S98
Ko Y-C, Cheng LS-C, Lee C-H et al (2000) Chinese food cooking and lung cancer in women nonsmokers. Am J Epidemiol 151(2):140–147
Bhangar S, Mullen NA, Hering SV et al (2011) Ultrafine particle concentrations and exposures in seven residences in northern California. Indoor Air 21(2):132–144
Evans GJ, Peers A, Sabaliauskas K (2008) Particle dose estimation from frying in residential settings. Indoor Air 18(6):499–510
Loomis D, Huang W, Chen G (2014) The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China. Chin J Cancer 33(4):189–196
Hamra GB, Guha N, Cohen A et al (2014) Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect 122(9):906–911
Katanoda K, Sobue T, Satoh H et al (2011) An association between long-term exposure to ambient air pollution and mortality from lung cancer and respiratory diseases in Japan. J Epidemiol 21(2):132–143
Gunier RB, Reynolds P, Hurley SE et al (2006) Estimating exposure to polycyclic aromatic hydrocarbons: a comparison of survey, biological monitoring, and geographic information system-based methods. Cancer Epidemiol Biomarkers Prev 15(7):1376–1381
Bell ML, Ebisu K (2012) Environmental inequality in exposures to airborne particulate matter components in the United States. Environ Health Perspect 120(12):1699–1704
Payne-Sturges D, Gee GC (2006) National environmental health measures for minority and low-income populations: Tracking social disparities in environmental health. Environ Res 102(2):154–171
Brooks N, Sethi R (1997) The distribution of pollution: community characteristics and exposure to air toxics. J Environ Econ Manag 32(2):233–250
Clark LP, Millet DB, Marshall JD (2014) National patterns in environmental injustice and inequality: outdoor NO2 air pollution in the United States. PLoS One 9(4):e94431
Downey L, Dubois S, Hawkins B et al (2008) Environmental inequality in metropolitan America. Organ Environ 21(3):270–294
Morello-Frosch R, Jesdale BM (2006) Separate and unequal: residential segregation and estimated cancer risks associated with ambient air toxics in U.S. metropolitan areas. Environ Health Perspect 114(3):386–393
Morello-Frosch R, Pastor M Jr, Porras C et al (2002) Environmental justice and regional inequality in southern California: implications for future research. Environ Health Perspect 110(Suppl 2):149–154
Quach T, Liu R, Nelson DO et al (2014) Disaggregating data on Asian American and Pacific Islander women to provide new insights on potential exposures to hazardous air pollutants in California. Cancer Epidemiol Biomarkers Prev 23(11):2218–2228
Woodruff TJ, Parker JD, Kyle AD et al (2003) Disparities in exposure to air pollution during pregnancy. Environ Health Perspect 111(7):942–946
Zou B, Peng F, Wan N et al (2014) Spatial cluster detection of air pollution exposure inequities across the United States. PLoS One 9(3):e91917
Yip FY, Pearcy JN, Garbe PL et al (2011) Unhealthy air quality—United States, 2006–2009. MMWR Suppl 60(1):28–32
Purdue MP, Hutchings SJ, Rushton L et al (2015) The proportion of cancer attributable to occupational exposures. Ann Epidemiol 25(3):188–192
International Agency for Research on Cancer (IARC) (2010) Agents classified by the IARC Monographs, vols 1–100. http://monographs.iarc.fr/ENG/Classification/index.php
Houghton AM (2013) Mechanistic links between COPD and lung cancer. Nat Rev Cancer 13(4):233–245
Pronk A, Coble J, Ji B-T et al (2009) Occupational risk of lung cancer among lifetime non-smoking women in Shanghai, China. Occup Environ Med 66(10):672–678
Tse LA, Yu IT, Qiu H et al (2012) Occupational risks and lung cancer burden for Chinese men: a population-based case-referent study. Cancer Causes Control 23(1):121–131
Brenner DR, Boffetta P, Duell EJ et al (2012) Previous lung diseases and lung cancer risk: a pooled analysis from the international lung cancer consortium. Am J Epidemiol 176(7):573–585
Brenner DR, McLaughlin JR, Hung RJ (2011) Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One 6(3):e17479
Wang XR, Yu IT, Chiu YL et al (2009) Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes Control 20(5):757–763
Mayne ST, Buenconsejo J, Janerich DT (1999) Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 149(1):13–20
Gorlova OY, Zhang Y, Schabath MB et al (2006) Never smokers and lung cancer risk: a case–control study of epidemiological factors. Int J Cancer 118(7):1798–1804
Kreuzer M, Heinrich J, Kreienbrock L et al (2002) Risk factors for lung cancer among nonsmoking women. Int J Cancer 100(6):706–713
Wu AH, Fontham ET, Reynolds P et al (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141(11):1023–1032
American Lung Association (2010) State of lung disease in diverse communities. American Lung Association, Washington, DC
Santillan AA, Camargo CA Jr, Colditz GA (2003) A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 14(4):327–334
Laurila AL, Anttila T, Läärä E et al (1997) Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer 74(1):31–34
Zhan P, Suo L-j, Qian Q et al (2011) Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer 47(5):742–747
Littman AJ, Jackson LA, Vaughan TL (2005) Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 14(4):773–778
Koh W-P, Chow VTK, Phoon M-C et al (2005) Lack of association between chronic Chlamydophila pneumoniae infection and lung cancer among nonsmoking Chinese women in Singapore. Int J Cancer 114(3):502–504
Littman AJ, Jackson LA, White E et al (2004) Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers. Clin Diagn Lab Immunol 11(3):615–617
Chaturvedi AK, Gaydos CA, Agreda P et al (2010) Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 19(6):1498–1505
zur Hausen H (1999) Papillomaviruses in human cancers. Proc Assoc Am Physicians 111:581–587
Ishiji T (2000) Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol 27(2):73–86
Klein F, Amin Kotb WFM, Petersen I (2009) Incidence of human papilloma virus in lung cancer. Lung Cancer 65(1):13–18
Hasegawa Y, Ando M, Kubo A et al (2014) Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. Lung Cancer 83(1):8–13
Wu CT, Chang YL, Shih JY et al (2005) The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 130:979–986
Weiss JM, Lacey JV, Shu X-O et al (2008) Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 168(11):1319–1325
Seow A, Koh W-P, Wang R et al (2009) Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 18(3):821–827
Liu Y, Inoue M, Sobue T et al (2005) Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 117(4):662–666
Huang KE, Xu L, I NN et al (2010) The Asian menopause survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 65(3):276–283
Schwartz AG, Ray RM, Cote ML et al (2015) Hormone use, reproductive history, and risk of lung cancer: the women’s health initiative studies. J Thorac Oncol 10(7):1004–1013
Pesatori AC, Carugno M, Consonni D et al (2013) Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). Br J Cancer 109(7):1954–1964
Cornfield J, Haenszel W, Hammond EC et al (2009) Smoking and lung cancer: recent evidence and a discussion of some questions. Int J Epidemiol 38(5):1175–1191
Chiolero A, Faeh D, Paccaud F et al (2008) Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87(4):801–809
Akbartabartoori M, Lean ME, Hankey CR (2005) Relationships between cigarette smoking, body size and body shape. Int J Obes (Lond) 29(2):236–243
Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578
Jih J, Mukherjea A, Vittinghoff E et al (2014) Using appropriate body mass index cut points for overweight and obesity among Asian Americans. Prev Med 65:1–6
Araneta MR, Kanaya AM, Hsu WC et al (2015) Optimum BMI cut points to screen Asian Americans for type 2 diabetes. Diabetes Care 38(5):814–820
Jee SH, Yun JE, Park EJ et al (2008) Body mass index and cancer risk in Korean men and women. Int J Cancer 123(8):1892–1896
Yang L, Yang G, Zhou M et al (2009) Body mass index and mortality from lung cancer in smokers and nonsmokers: a nationally representative prospective study of 220,000 men in China. Int J Cancer 125(9):2136–2143
Parr CL, Batty GD, Lam TH et al (2010) Body-mass index and cancer mortality in the Asia-Pacific cohort studies collaboration: pooled analyses of 424 519 participants. Lancet Oncol 11(8):741–752
International Agency for Research on Cancer, World Health Organization (2003). In: IARC Handbooks of Cancer Prevention. Fruit and vegetables, vol 8. IARC Press, Lyon
Vieira AR, Abar L, Vingeliene S et al (2015) Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis. Ann Oncol 27(1):81–96. doi:10.1093/annonc/mdv381
Conaway CC, Yang YM, Chung FL (2002) Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 3(3):233–255
Hecht SS (2000) Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32(3–4):395–411
Wu QJ, Xie L, Zheng W et al (2013) Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta-analysis. Ann Oncol 24(7):1918–1924
Lam TK, Gallicchio L, Lindsley K et al (2009) Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev 18(1):184–195
Kurose K, Sugiyama E, Saito Y (2012) Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet 27(1):9–54
Goralczyk R (2009) Beta-carotene and lung cancer in smokers: review of hypotheses and status of research. Nutr Cancer 61(6):767–774
Virtamo J, Taylor PR, Kontto J et al (2014) Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the alpha-tocopherol, beta-carotene cancer prevention study. Int J Cancer 135(1):178–185
Cook NR, Le IM, Manson JE et al (2000) Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians’ Health Study (United States). Cancer Causes Control 11(7):617–626
The ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4(1):1–10
Rautalahti M, Albanes D, Virtamo J et al (1997) Beta-carotene did not work: aftermath of the ATBC study. Cancer Lett 114(1–2):235–236
Omenn GS, Goodman G, Thornquist M et al (1994) The β-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 54(7 Supplement):2038s–2043s
Druesne-Pecollo N, Latino-Martel P, Norat T et al (2010) Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer 127(1):172–184
Tanvetyanon T, Bepler G (2008) Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers. Cancer 113(1):150–157
Gallicchio L, Boyd K, Matanoski G et al (2008) Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 88(2):372–383
Männistö S, Smith-Warner SA, Spiegelman D et al (2004) Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 13(1):40–48
Reid ME, Duffield-Lillico AJ, Garland L et al (2002) Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 11(11):1285–1291
Fritz H, Kennedy D, Fergusson D et al (2011) Selenium and lung cancer: a systematic review and meta analysis. PLoS One 6(11):e26259
Slatore CG, Littman AJ, Au DH et al (2008) Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med 177(5):524–530
Wu Q-J, Xiang Y-B, Yang G et al (2015) Vitamin E intake and the lung cancer risk among female nonsmokers: a report from the Shanghai Women’s Health Study. Int J Cancer 136(3):610–617
Szabo E, Mao JT, Lam S et al (2013) Chemoprevention of lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e40S–e60S
Fortmann SP, Burda BU, Senger CA, et al (2013) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: a systematic evidence review for the U.S. Preventive Services Task Force. Rockville, MD
Freudenheim JL, Ritz J, Smith-Warner SA et al (2005) Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am J Clin Nutr 82(3):657–667
Chao C (2007) Associations between beer, wine, and liquor consumption and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 16(11):2436–2447
Bagnardi V, Rota M, Botteri E et al (2011) Alcohol consumption and lung cancer risk in never smokers: a meta-analysis. Ann Oncol 22(12):2631–2639
Li Y, Yang H, Cao J (2011) Association between alcohol consumption and cancers in the Chinese population—a systematic review and meta-analysis. PLoS One 6(4):e18776
Xu X, Duncan AM, Merz BE et al (1998) Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 7(12):1101–1108
Masilamani M, Wei J, Sampson H (2012) Regulation of the immune response by soybean isoflavones. Immunol Res 54(1–3):95–110
Yang W-S, Va P, Wong M-Y et al (2011) Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies. Am J Clin Nutr 94(6):1575–1583
Yang G, Shu XO, Chow W-H et al (2012) Soy food intake and risk of lung cancer: evidence from the Shanghai women’s health study and a meta-analysis. Am J Epidemiol 176(10):846–855
Wu SH, Liu Z (2013) Soy food consumption and lung cancer risk: a meta-analysis using a common measure across studies. Nutr Cancer 65(5):625–632
Wang L, Zhang X, Liu J et al (2014) Tea consumption and lung cancer risk: a meta-analysis of case–control and cohort studies. Nutrition 30(10):1122–1127
Yang WS, Wong MY, Vogtmann E et al (2012) Meat consumption and risk of lung cancer: evidence from observational studies. Ann Oncol 23(12):3163–3170. doi:10.1093/annonc/mds207
Smith-Warner SA, Ritz J, Hunter DJ et al (2002) Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomarkers Prev 11(10):987–992
Tasevska N, Cross AJ, Dodd KW et al (2011) No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial. Int J Cancer 128(2):402–411
Tasevska N, Sinha R, Kipnis V et al (2009) A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr 89(6):1884–1894
Linseisen J, Rohrmann S, Bueno-de-Mesquita B et al (2011) Consumption of meat and fish and risk of lung cancer: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control 22(6):909–918
American Institute for Cancer Research/World Cancer Research Fund (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108
U.S. Department of Health and Human Services (2004) The health consequences of smoking: a report of the Surgeon General
Coté ML, Liu M, Bonassi S et al (2012) Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer 48(13):1957–1968
McKay JD, Hung RJ, Gaborieau V et al (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40(12):1404–1406
Wang Y, Broderick P, Webb E et al (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 40(12):1407–1409
Broderick P, Wang Y, Vijayakrishnan J et al (2009) Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res 69(16):6633–6641
Hung RJ, McKay JD, Gaborieau V et al (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452(7187):633–637
Thorgeirsson TE, Geller F, Sulem P et al (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452(7187):638–642
Thorgeirsson TE, Gudbjartsson DF, Surakka I et al (2010) Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 42(5):448–453
Amos CI, Wu X, Broderick P et al (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40(5):616–622
Ito H, McKay JD, Hosono S et al (2012) Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese population. J Thorac Oncol 7(5):790–798
Wu C, Hu Z, Yu D et al (2009) Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res 69(12):5065–5072
Bae EY, Lee SY, Kang BK et al (2012) Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology 17(4):699–706
Jin G, Zhu M, Yin R et al (2015) Low-frequency coding variants at 6p21.33 and 20q11.21 are associated with lung cancer risk in Chinese populations. Am J Hum Genet 96(5):832–840
Shiraishi K, Kunitoh H, Daigo Y et al (2012) A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat Genet 44(8):900–903
Machiela MJ, Hsiung CA, Shu X-O et al (2015) Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia. Int J Cancer 137(2):311–319
Dong J, Jin G, Wu C et al (2013) Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in Han Chinese. PLoS Genet 9(1):e1003190
Yoon K-A, Park JH, Han J et al (2010) A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet 19(24):4948–4954
Carlsten C, Sagoo GS, Frodsham AJ et al (2008) Glutathione S-Transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167(7):759–774
Yang X, Qiu M-T, Hu J-W et al (2013) GSTT1 null genotype contributes to lung cancer risk in Asian populations: a meta-analysis of 23 studies. PLoS One 8(4):e62181
Ji Y-N, Wang Q, Suo L-J (2012) CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis. PLoS One 7(8):e43397
Zhang Q, Jin H, Wang L et al (2014) Lung cancer risk and genetic variants in East Asians: a meta-analysis. Tumour Biol 35(6):5173–5179
Benowitz NL, Jacob P, Fong I et al (1994) Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 268(1):296–303
Nakajima M, Yokoi T (2005) Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. Drug Metab Pharmacokinet 20(4):227–235
Nakajima M, Fukami T, Yamanaka H et al (2006) Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther 80(3):282–297
Park SL, Tiirikainen MI, Patel YM et al (2016) Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity. Carcinogenesis 37(3):269–279
Liu Y-l, Xu Y, Li F et al (2013) CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis. Tumour Biol 34(5):2651–2657
Park SL, Carmella SG, Ming X et al (2015) Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer. Cancer Epidemiol Biomarkers Prev 24(3):561–569
Lan Q, Hsiung CA, Matsuo K et al (2012) Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 44(12):1330–1335
Ahn M-J, Won H-H, Lee J et al (2012) The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations. Hum Genet 131(3):365–372
Miki D, Kubo M, Takahashi A et al (2010) Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet 42(10):893–896
Hosgood HD III, Wang W-C, Hong Y-C et al (2012) Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia. Hum Genet 131(7):1197–1203
Wang Z, Seow WJ, Shiraishi K et al (2016) Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women. Hum Mol Genet 25(3):620–629
National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409
U.S. Preventive Services Task Force. Screening for Lung Cancer, Topic Page. http://www.uspreventiveservicestaskforce.org/uspstf/uspslung.htm
Goulart BHL, Bensink ME, Mummy DG et al (2012) Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw 10(2):267–275
Kovalchik SA, Tammemagi M, Berg CD et al (2013) Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 369(3):245–254
Bach PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of ct screening for lung cancer: a systematic review. JAMA 307(22):2418–2429
Kumar V, Becker K, Zheng HX et al (2015) The performance of NLST screening criteria in Asian lung cancer patients. BMC Cancer 15(1):1–6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Park, S.L., Stram, D.O., De Rouen, M.C., Gomez, S.L., Wu, A.H., Cheng, I. (2016). Lung Cancer Among Asian Americans. In: Wu, A., Stram, D. (eds) Cancer Epidemiology Among Asian Americans. Springer, Cham. https://doi.org/10.1007/978-3-319-41118-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-41118-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41116-3
Online ISBN: 978-3-319-41118-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)